hypertension. High blood pressure
Conditions
Interventions
Intervention 1: Placebo, 100 mg, once daily for three months. Intervention 2: Coenzyme q10, 100 mg orally, once daily for three months.
Placebo
Treatment - Drugs
Placebo, 100 mg, once daily for three months
Coenzyme q10, 100 mg orally, once daily for three months
Sponsors
Shahid Sadughi University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
35 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: willingness to cooperate in the project and complete a written informed consent, diagnosis of hypertensive patients based on diagnostic criteria and clinical examination by a physician, No pregnant or breastfeeding women, the absence of any autoimmune disorders, cardio - vascular, or renal diseases, lack of nutritional supplements during the past six months Exclusion criteria: diabetes mellitus type 1 or type 2, the history of disease such as myocardial infarction, cardiac dysfunction, cardiac arrhythmia, angina and kidney disease, autoimmune diseases like MS, rheumatism, etc, BMI> 40, factors causing secondary hypertension, supplementation of vitamin, mineral or other nutritional supplements, Alcohol or drug use, Incidence of severe side effects, non-compliance with study protocol
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL6. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;Hypertension. Timepoint: At At baseline, weeks after the sixth and twelfth week baseline. Method of measurement: Measured by standard mercury blood pressure measuring device sitting.;IL2. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;Hs-CRP. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;TNF-a. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;Adiponectin. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeied Mohammad Mohammadi Zarchi
Shahid Sadughi University of Medical Sciences and Health Services
Outcome results
None listed